ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 568,65
-0,84%
Dow Jones
40 211,72
0,00%
DAX
18 482,76
-0,63%
Brent Oil
82,945
-1,65%
Bitcoin
63 740,53
-1,71%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) Actualités

PRTC

PureTech Health (PRTC)

PureTech Health PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRTC
DateHeureSourceTitreSymboleSociété
08/07/202115h05Business WirePureTech Founded Entity Sonde Health Announces Collaboration with Qualcomm Technologies for Use of Vocal Biomarker Technology...NASDAQ:PRTCPureTech Health PLC
07/07/202113h00Business WirePureTech Announces Clinical Trial & Supply Agreement with BeiGene to Evaluate LYT-200 & Tislelizumab in Patients with Difficu...NASDAQ:PRTCPureTech Health PLC
30/06/202113h00Business WirePureTech Founded Entity Vedanta Biosciences Announces New Data from Phase 1 Study of VE202 for the Treatment of Inflammatory ...NASDAQ:PRTCPureTech Health PLC
29/06/202122h01Business WireVedanta Biosciences Presents New Data from Phase 1 Study of VE202, Its Rationally-Defined Consortium for the Treatment of Inf...NASDAQ:PRTCPureTech Health PLC
23/06/202114h46Business WirePureTech Founded Entity Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety & Tolerability of Kar...NASDAQ:PRTCPureTech Health PLC
16/06/202113h00Business WirePureTech Acquires Remaining Interest in Founded Entity Alivio TherapeuticsNASDAQ:PRTCPureTech Health PLC
27/05/202122h28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
27/05/202119h32Business WireResults of Annual General MeetingNASDAQ:PRTCPureTech Health PLC
27/05/202115h50Business WirePureTech Founded Entity Gelesis Presents Findings on Plenity®-Induced Weight Loss at the American Association of Clinical En...NASDAQ:PRTCPureTech Health PLC
26/05/202114h05Business WirePureTech Founded Entity Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital TherapeuticsNASDAQ:PRTCPureTech Health PLC
25/05/202113h00Business WirePureTech to Present at the Jefferies Virtual Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
12/05/202113h00Business WirePureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung DisordersNASDAQ:PRTCPureTech Health PLC
28/04/202117h13Business WirePureTech Announces Nature Publication Supporting Modulation of Meningeal Lymphatics to Target Alzheimer’s Disease PathologiesNASDAQ:PRTCPureTech Health PLC
26/04/202114h05Business WirePureTech Founded Entity Gelesis Appoints Procter & Gamble Veteran Jane Wildman to Board of DirectorsNASDAQ:PRTCPureTech Health PLC
15/04/202114h36Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PRTCPureTech Health PLC
15/04/202113h00Business WireVedanta Biosciences to Present at the 2021 Jefferies Virtual Microbiome-Based Therapeutics SummitNASDAQ:PRTCPureTech Health PLC
15/04/202108h00Business WirePureTech Announces Annual Results for Year Ended December 31, 2020NASDAQ:PRTCPureTech Health PLC
12/04/202113h00Business WirePureTech Presents Promising Preclinical Data from LYT-210 Immuno-Oncology Program at American Association for Cancer Research...NASDAQ:PRTCPureTech Health PLC
07/04/202113h00Business WirePureTech to Present at Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
07/04/202111h15Business WirePureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital & Vanderbilt University...NASDAQ:PRTCPureTech Health PLC
26/03/202113h07Business WirePureTech Founded Entity Akili Announces the Results of EndeavorRx™ Clinical Study in Pediatric ADHD Published in Nature Dig...NASDAQ:PRTCPureTech Health PLC
18/03/202108h00Business WirePureTech Announces Board Member RetirementNASDAQ:PRTCPureTech Health PLC
15/03/202108h00Business WirePureTech: Notice of ResultsNASDAQ:PRTCPureTech Health PLC
03/03/202113h00Business WirePureTech to Present at The Barclays Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
02/03/202113h55Business WirePureTech Founded Entity Karuna Therapeutics Announces Pricing of Public Offering of Common StockNASDAQ:PRTCPureTech Health PLC
02/03/202113h00Business WireVedanta Biosciences to Present at Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
25/02/202115h17Business WirePureTech Announces Publication of Glyph™ Platform Preclinical Proof-of-Concept Study in Journal of Controlled ReleaseNASDAQ:PRTCPureTech Health PLC
25/02/202108h00Business WirePureTech Founded Entity Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Pha...NASDAQ:PRTCPureTech Health PLC
18/02/202113h00Business WirePureTech to Present at The SVB Leerink 10th Annual Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
16/02/202121h53Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC

Dernières Valeurs Consultées

EU
BEL20
Bel 20
EU
GLE
Societe Generale
EU
ACA
Credit Agricole
EU
AF
Air FranceKLM
EU
PX4
SBF 120
EU
BNP
BNP Paribas
COIN
ETHUSD
Ethereum
NYSE
DIS
Walt Disney
EU
VK
Vallourec
NYSE
MRK
Merck
EU
ML
Michelin
EU
ORA
Orange
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés